{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:08:10Z","timestamp":1790125690819,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.mayocp.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T05:15:52Z","timestamp":1425273352000},"page":"408-414","source":"Crossref","is-referenced-by-count":34,"title":["Best Practices for Patients With Chronic Migraine"],"prefix":"10.1016","volume":"90","author":[{"given":"Amaal J.","family":"Starling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.mayocp.2015.01.010_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/2049463712459691","article-title":"Headache disorders: differentiating and managing the common subtypes","volume":"6","author":"Ahmed","year":"2012","journal-title":"Br J Pain"},{"issue":"12","key":"10.1016\/j.mayocp.2015.01.010_bib2","first-page":"2087","article-title":"Diagnosis of migraine headache","volume":"74","author":"Ebell","year":"2006","journal-title":"Am Fam Physician"},{"issue":"5","key":"10.1016\/j.mayocp.2015.01.010_bib3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","article-title":"Global prevalence of chronic migraine: a systematic review","volume":"30","author":"Natoli","year":"2010","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.mayocp.2015.01.010_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The International Classification of Headache Disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.mayocp.2015.01.010_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102410381145","article-title":"Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS)","volume":"31","author":"Blumenfeld","year":"2011","journal-title":"Cephalalgia"},{"issue":"8","key":"10.1016\/j.mayocp.2015.01.010_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1212\/01.wnl.0000323925.29520.e7","article-title":"Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.01.010_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11916-010-0159-x","article-title":"Treatment of chronic migraine","volume":"15","author":"Diener","year":"2011","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2015.01.010_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11916-011-0233-z","article-title":"Defining the differences between episodic migraine and chronic migraine","volume":"16","author":"Katsarava","year":"2012","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp042897","article-title":"Clinical practice: chronic daily headache","volume":"354","author":"Dodick","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2015.01.010_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1526-4610.2011.01954.x","article-title":"Chronic migraine, classification, differential diagnosis, and epidemiology","volume":"51","author":"Lipton","year":"2011","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11910-010-0175-6","article-title":"Migraine chronification","volume":"11","author":"Bigal","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jnnp.2007.134023","article-title":"Migraine prevention","volume":"7","author":"Dodick","year":"2007","journal-title":"Pract Neurol"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","article-title":"Topiramate Chronic Migraine Study Group. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mayocp.2015.01.010_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","article-title":"Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study","volume":"27","author":"Diener","year":"2007","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.mayocp.2015.01.010_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1212\/01.WNL.0000100121.58594.11","article-title":"Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study","volume":"61","author":"Spira","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","article-title":"Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study","volume":"42","author":"Saper","year":"2002","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.mayocp.2015.01.010_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","article-title":"Double-blind trial of fluoxetine: chronic daily headache and migraine","volume":"34","author":"Saper","year":"1994","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1046\/j.1526-4610.2002.02125.x","article-title":"Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study","volume":"42","author":"Krymchantowski","year":"2002","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1526-4610.1991.hed3102071.x","article-title":"Valproate in the treatment of persistent chronic daily headache: an open label study","volume":"31","author":"Mathew","year":"1991","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.mayocp.2015.01.010_bib20","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","article-title":"A\u00a0randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis","volume":"58","author":"Freitag","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0030-1249224","article-title":"Diagnosis and management of chronic daily headache","volume":"30","author":"Garza","year":"2010","journal-title":"Semin Neurol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mayocp.2015.01.010_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10194-008-0002-5","article-title":"The effect of sodium valproate on chronic daily headache and its subgroups","volume":"9","author":"Yurekli","year":"2008","journal-title":"J\u00a0Headache Pain"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.wnf.0000192136.46145.44","article-title":"Efficacy of topiramate and valproate in chronic migraine","volume":"28","author":"Bartolini","year":"2005","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"issue":"17","key":"10.1016\/j.mayocp.2015.01.010_bib26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mayocp.2015.01.010_bib27","series-title":"BOTOX\u00ae (onabotulinumtoxinA) Full Prescribing Information","year":"2011"},{"issue":"7","key":"10.1016\/j.mayocp.2015.01.010_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.mayocp.2015.01.010_bib29","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mayocp.2015.01.010_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/0333102414547138","article-title":"Adherence to oral migraine preventive-medications among patients with chronic migraine","author":"Hepp","year":"2014","journal-title":"Cephalalgia"},{"issue":"4D","key":"10.1016\/j.mayocp.2015.01.010_bib31","article-title":"Finding a fit: strategies for chronic migraine prophylaxis","volume":"6","author":"Dodick","year":"2006","journal-title":"Johns Hopkins Adv Stud Med"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1526-4610.2001.041006554.x","article-title":"Precipitating and aggravating factors of migraine versus tension-type headache","volume":"41","author":"Spierings","year":"2001","journal-title":"Headache"},{"issue":"3, suppl","key":"10.1016\/j.mayocp.2015.01.010_bib33","first-page":"S58","article-title":"Migraine: diagnosis, management, and new treatment options","volume":"8","author":"Gallagher","year":"2002","journal-title":"Am J Manag Care"},{"issue":"5","key":"10.1016\/j.mayocp.2015.01.010_bib34","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1468-2982.2007.01303.x","article-title":"The triggers or precipitants of the acute migraine attack","volume":"27","author":"Kelman","year":"2007","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.mayocp.2015.01.010_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WCO.0b013e32832b2387","article-title":"What predicts the change from episodic to chronic migraine?","volume":"22","author":"Bigal","year":"2009","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.mayocp.2015.01.010_bib36","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1468-2982.2004.00691.x","article-title":"Transformed migraine and medication overuse in a tertiary headache centre\u2014clinical characteristics and treatment outcomes","volume":"24","author":"Bigal","year":"2004","journal-title":"Cephalalgia"},{"issue":"6, suppl 3","key":"10.1016\/j.mayocp.2015.01.010_bib37","first-page":"S26","article-title":"Chronic refractory headache","volume":"43","author":"Mathew","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mayocp.2015.01.010_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1212\/WNL.61.2.154","article-title":"Chronic daily headache: is analgesic overuse a cause or a consequence?","volume":"61","author":"Lipton","year":"2003","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mayocp.2015.01.010_bib39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.mayocp.2015.01.010_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(04)00824-5","article-title":"Medication-overuse headache: a worldwide problem","volume":"3","author":"Diener","year":"2004","journal-title":"Lancet Neurol"},{"issue":"22","key":"10.1016\/j.mayocp.2015.01.010_bib41","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1212\/01.wnl.0000335946.53860.1d","article-title":"Excessive acute migraine medication use and migraine progression","volume":"71","author":"Bigal","year":"2008","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2015.01.010_bib42","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1007\/s10072-010-0297-2","article-title":"Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence","volume":"31","author":"Finocchi","year":"2010","journal-title":"Neurol Sci"},{"issue":"4","key":"10.1016\/j.mayocp.2015.01.010_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1526-4610.2007.00760.x","article-title":"Pharmacological approaches to managing migraine and associated comorbidities\u2014clinical considerations for monotherapy versus polytherapy","volume":"47","author":"Silberstein","year":"2007","journal-title":"Headache"},{"issue":"14","key":"10.1016\/j.mayocp.2015.01.010_bib44","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/0333102411419681","article-title":"Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls","volume":"31","author":"Varkey","year":"2011","journal-title":"Cephalalgia"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619615000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T12:26:51Z","timestamp":1566390411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619615000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0025619615000683"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2015.01.010","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}